Levonorgetsrel And Ethinyl Estradiol Kit
Product Images NDC 31722-944

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Levonorgetsrel And Ethinyl Estradiol (NDC 31722-944). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-label (Carton Label)

Packaging label for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.1 mg/0.02 mg, in a kit form. The label shows the product name and strength prominently with a dosage form of oral tablets. The kit contains 3 blister cards of 28 tablets each. The labeler is Camber Pharmaceuticals, Inc. The label includes warnings about storage, usage instructions, and a note that the product is a prescription-only oral contraceptive. Manufactured by Cyndea Pharma, S.L. in Spain, distributed by Camber Pharmaceuticals, Inc., Piscataway, USA.*

FDA Label Image

Day-label (Day Label)

An instructional diagram of a 28-day oral contraceptive pill pack for Levonorgetsrel and Ethinyl Estradiol. It shows circles representing daily pills arranged in four rows labeled Week 1 to Week 4, with days of the week (Sunday to Saturday) indicated at the top. Arrows guide the sequence to take the pills, starting from Sunday. A placeholder area is labeled to place the day label.*

FDA Label Image

Ethinylestradiolstructure (Ethinylestradiolstructure)

Chemical structure diagram of Levonorgetsrel and Ethinyl Estradiol, showing the molecular framework with rings, hydroxyl (OH) groups, and other functional groups typical to these compounds.*

FDA Label Image

Figure-3 (Figure 3)

A forest plot chart comparing effect estimates (OR, RR) for studies on COC (combined oral contraceptive) use versus never COC use, and current COC use versus never use. The plot includes study names, effect estimates with confidence intervals, and a horizontal axis titled 'Effect Estimate' ranging from about -1.5 to 2.0.*

FDA Label Image

Levonorgestrelandethinylestradiolcamberlogo1 (Levonorgestrelandethinylestradiolcamberlogo1)

FDA Label Image

Levonorgestrelandethinylestradiolcamberlogo2 (Levonorgestrelandethinylestradiolcamberlogo2)

FDA Label Image

Levonorgestrelandethinylestradiolcamberlogo3 (Levonorgestrelandethinylestradiolcamberlogo3)

FDA Label Image

Levonorgestrelandethinylestradiolfigure1 (Levonorgestrelandethinylestradiolfigure1)

Two line graphs showing concentration over time (hours) for Levonorgestrel and Ethinyl Estradiol. Each graph includes data points for Day 1, Day 5, and Day 21, demonstrating changes in drug concentration (ng/mL or pg/mL) up to 96 hours after administration.*

FDA Label Image

Levonorgestrelandethinylestradiolfigure2 (Levonorgestrelandethinylestradiolfigure2)

A bar chart depicting data categorized by age groups (15-24, 25-34, 35-44, 45+) and comparing four categories: ever-users (nonsmokers), controls (nonsmokers), ever-users (smokers), and controls (smokers). The y-axis represents a numerical scale up to 200, with the highest values observed in the 45+ age group for ever-users (smokers).*

FDA Label Image

Levonorgestrelstructure (Levonorgestrelstructure)

Chemical structure of Levonorgetsrel and Ethinyl Estradiol, depicted as a steroid framework with various functional groups including hydroxyl and alkyne groups visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.